Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schenk

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Clinical Chemistry|December 30, 2025
Evaluation of Total Bilirubin in a National Quality ProgramLauren E H Westenberg, Marith van Schrojenstein Lantman, Miranda van Berkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Clinical Chemistry|December 30, 2025
Evaluation of Total Bilirubin in a National Quality ProgramLauren E H Westenberg, Marith van Schrojenstein Lantman, Miranda van Berkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
Pageof 9